Who are Opioid stable treatment's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): NALBUPHINE HYDROCHLORIDE, Oxycodone and acetaminophen combination treatment, Acetaminophen/Codeine, Hydrocodone-Acetaminophen, Acetaminophen, ketoprofen, morphine, hydrocodone plus acetaminophen.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/opioid-stable-treatment.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Opioid stable treatment — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Opioid stable treatment (Opioid stable treatment) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Opioid agonist maintenance therapy. Area: Addiction Medicine / Substance Use Disorder.

phase 3 Opioid agonist maintenance therapy Mu opioid receptor Addiction Medicine / Substance Use Disorder Small molecule Live · refreshed every 30 min

Target snapshot

Opioid stable treatment (Opioid stable treatment) — Rigshospitalet, Denmark. Opioid stable treatment maintains consistent opioid dosing to prevent withdrawal and reduce illicit drug use in opioid-dependent patients.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Opioid stable treatment TARGET	Opioid stable treatment	Rigshospitalet, Denmark	phase 3	Opioid agonist maintenance therapy	Mu opioid receptor
NALBUPHINE HYDROCHLORIDE	NALBUPHINE HYDROCHLORIDE		marketed		kappa opioid receptors, mu opioid receptors	1979-01-01
Oxycodone and acetaminophen combination treatment	Oxycodone and acetaminophen combination treatment	Barrie Urology Associates	marketed	Opioid analgesic combination	Mu opioid receptor (oxycodone); cyclooxygenase enzymes (acetaminophen)
Acetaminophen/Codeine	Acetaminophen/Codeine	University of Pennsylvania	marketed	Opioid analgesic combination	Mu opioid receptor (codeine); COX enzymes (acetaminophen)
Hydrocodone-Acetaminophen	Hydrocodone-Acetaminophen	Henry Ford Health System	marketed	Opioid analgesic combination	Mu opioid receptor (hydrocodone); COX inhibitor (acetaminophen)
Acetaminophen, ketoprofen, morphine	Acetaminophen, ketoprofen, morphine	University Hospital, Montpellier	marketed	Analgesic combination (acetaminophen + NSAID + opioid)	Prostaglandin synthesis (acetaminophen), COX-1/COX-2 (ketoprofen), mu opioid receptor (morphine)
hydrocodone plus acetaminophen	hydrocodone plus acetaminophen	University of California, Davis	marketed	Opioid analgesic combination	Mu opioid receptor (hydrocodone); COX inhibitor (acetaminophen)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Opioid agonist maintenance therapy class)

Rigshospitalet, Denmark · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Opioid stable treatment — Competitive Intelligence Brief. https://druglandscape.com/ci/opioid-stable-treatment. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab